Abiopharma

News list

Scott Byron C 🟡 adjusted position in 3.8K shares (1 derivative) of ACCURAY INC (ARAY) at $0.82 Transaction Date: Dec 31, 2025 | Filing ID: 000329

Full text

News bot Jan. 10, 2026, 12:35 a.m.
🔍 Scott Byron C (Executive)

Company: ACCURAY INC (ARAY)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 9,433
- Total shares sold: 13,207
Detailed Transactions and Holdings:
- Acquired 9,433 shares of Common Stock (Direct)
  Date: 2025-12-31 | Code: M | equity_swap_involved: false | shares_owned_after: 162,727.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 3,774 shares of Common Stock at $0.8246 per share (Direct)
  Date: 2025-12-31 | Code: F | equity_swap_involved: false | shares_owned_after: 158,953.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 9,433 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-31 | Code: M | equity_swap_involved: false | shares_owned_after: 47,170.00 | transaction_form_type: 4 | Footnotes: F3, F1, F4, F4
Footnotes:
- F1: Shares vesting were accelerated due to Mr. Scott's retirement from the Board of Directors on December 31, 2025.
- F2: These shares were forfeited due to a cash settlement election made by the director in the grant agreement.
- F3: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F4: This represents a Restricted Stock Unit that vests 100% on 11/13/2026.